User Rating: 5 / 5
Joins Nanovation Partners in a commercialization agreement on nanotube processes
Intellectual property from UCSD, WSU, UCF, Michigan Tech, N2 Biomedical, and Nanovation Partners represents the most comprehensive portfolio available to license with respect to implant nanotube surface treatment
User Rating: 5 / 5
The WBC2016 10th World Biomaterials congress held in Montreal, Canada, May 17-22 was a good meeting with respect to nanotubes. Actually, over a dozen papers were presented related to TiO2 nanotubes. There were as many presentations discussing nanotexturing as any other single topic.
User Rating: 0 / 5
“I DO not depend on figures at all,” said Thomas Edison. “I try an experiment and reason out the result, somehow, by methods which I could not explain.” And so it was that by testing 1,600 different materials, from coconut fibre to fishing line and even a hair from a colleague’s beard
User Rating: 5 / 5
We are already familiar with the effects of Phase 1 of the nanotechnology revolution. It is referred to Graphene, a super strong waterproofing material for water purifying and battery power improving.
User Rating: 4 / 5
The Leona M. and Harry B. Helmsley Charitable Trust has awarded a three-year $3,304,400 grant to the Tel Aviv University Leona M. and Harry B. Helmsley Nanotechnology Research Fund to launch research on personalized "theranostic" nanomedicines for cancer, cardiovascular, and inflammatory diseases. Theranostics, combining diagnostics and therapeutics, are a key component of the rapidly growing field of personalized medicine.
Starting in the mid 2000’s, the founders of Nanovation Partners LLC sponsored research at the University of California at San Diego (UCSD) in the lab of Sungho Jin, PhD. This research showed enhanced osseointegration and reduced implant surface infection by forming thousands of rows of tiny metal oxide nanotubes